Celldex Therapeutics, Inc. (FRA:TCE2)
Germany · Delayed Price · Currency is EUR 23.60
+0.20 (0.85%)
At close: Jan 9, 2026
Celldex Therapeutics Market Cap
Celldex Therapeutics has a market cap or net worth of €1.56 billion as of January 9, 2026. Its market cap has decreased by -1.04% in one year.
Market Cap
1.56B
Enterprise Value
1.06B
Revenue
2.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
€23.60
Market Cap Chart
Since March 10, 2008, Celldex Therapeutics's market cap has increased from 74.63M to 1.56B, an increase of 1,995.92%. That is a compound annual growth rate of 18.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.56B | 1.76% |
| Dec 31, 2025 | 1.54B | -5.08% |
| Dec 31, 2024 | 1.62B | -17.48% |
| Dec 29, 2023 | 1.96B | -0.10% |
| Dec 30, 2022 | 1.96B | 23.89% |
| Dec 31, 2021 | 1.59B | 179.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |